Skip to main content

Table 2 Mean (SD) of anthropometric and clinical data among IRG and NIRG

From: Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study

  NIRG IRG p
mean sd mean sd
Age, y 66.22 8.93 62.39 9.13 < 0.001
Waist circumference, cm 92.87 7.96 108.58 9.90 < 0.001
Weight, kg 67.91 9.57 87.18 13.7 < 0.001
BMI, kg/m2 25.60 2.30 33.29 3.94 < 0.001
Cholesterol total, mg/dL 160.39 35.30 161.74 36.61 0.72
LDL cholesterol, mg/dL 84.73 28.65 81.75 27.43 0.32
HDL cholesterol, mg/dL 46.78 12.88 44.75 15.80 0.18
Triacylglycerol, mg/dL 142.99 80.49 183.97 125.61 < 0.001
Glycaemia, mg/dL 107.90 37.85 112.78 37.77 0.22
Insulin, mIU/mL 8.19 4.73 15.12 11.88 < 0.001
HOMA 1.11 0.66 1.89 1.20 < 0.001
Systolic blood pressure, mmHg 129.73 20.23 136.85 22.87 < 0.001
Diastolic blood pressure, mmHg 75.27 11.68 81.28 15.55 0.040
CRP, mg/dL 6.00 12.70 7.90 18.60 0.002
Adiponectin, mg/mL 9601.43 6679.80 8149.63 5061.45 0.124
IL-10, pg/mL 21.97 21.62 23.20 22.51 0.499
IL-12, pg/mL 6.88 33.28 4.98 10.70 0.119
IL-1 b, pg/mL 1.11 4.25 2.28 18.27 0.38
IL-6, pg/mL 7.46 13.10 9.04 13.46 0.002
IL-8, pg/mL 4.82 2.78 4.81 2.61 0.964
TNF-a, pg/mL 7.85 5.23 8.49 5.98 0.395
Myristic fatty acid - C14:0 (%) 0.47 0.33 0.60 0.42 0.007
Palmitic fatty acid- C16:0 (%) 24.47 3.50 25.28 3.55 0.07
Palmitoleic fatty acid - C16:1 (%) 1.59 0.74 1.80 0.66 0.001
Estearic fatty acid - C18:0 (%) 12.11 1.67 11.82 1.78 0.18
Oleic fatty acid - C18:1 (%) 20.31 3.80 21.14 3.47 0.07
Linoleic fatty acid - C18:2 (%) 22.85 3.87 22.25 3.38 0.19
α-linolenic fatty acid- C18:3 (%) 0.75 0.33 0.71 0.26 0.322
Eicosatrienoic fatty acid - C20:3 (%) 2.55 0.61 2.57 0.64 0.78
Araquidonic fatty acid -C20:4 (%) 11.42 2.88 10.59 2.61 0.02
Eicosapentaenoic fatty acid - C20:5 (%) 0.74 0.49 0.70 0.29 0.507
Docosapenatenoic fatty acid - C22:5 (%) 0.97 0.27 0.90 0.23 0.02
Docosahexaenoic fatty acid - C22:6 (%) 2.79 1.09 2.53 0.85 0.06
  1. IRG group of patients with insulin resistance, NIRG group of patients non-insulin resistant, BMI body-mass index, CRP C-reactive protein, HDL high-density lipoprotein, HOMA homeostasis model assessment, IL interleukin, LDL low-density lipoprotein, TNF tumor necrosis factor
  2. Data are expressed as mean (standard deviation). P < 0.05 indicate the significant difference between groups